Skip to main content
Premium Trial:

Request an Annual Quote

PathoGenome Version 4.0 Contains New Sequences


WALTHAM, Mass.--Genome Therapeutics announced that it has produced the first sequences of virulent strains of Enterobacter cloacae and Acinetobacter baumannii, two gram-negative bacteria that are major causes of serious infections. The sequences are now available in Version 4.0 of the company's proprietary microbial sequence database, PathoGenome.

The genomic information of E. cloacae and A. baumannii was derived from recent clinical isolates and sequenced using a whole-genome shotgun approach, with greater than six-fold sequence coverage, Genome Therapeutics said. The firm's industrial-scale sequencing and bioinformatics capabilities have identified more than 5,000 new E. cloacae genes by sequencing 5 million base pairs, and more than 4,000 A. baumannii genes by sequencing 3.8 million base pairs. The company said it has applied for patents on the sequences. Genome Therapeutics called PathoGenome an important tool for developing new antibiotics that combat drug-resistant bacteria.

Filed under

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.